Faculty profile

Bernard Candas

ResearcherSocial and Preventive MedicineUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses and email address may be missing. Find their university profile.

Bernard Candas

Researcher

Social and Preventive Medicine

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
4 publications in the last five years, latest in 2024.
Principal investigator on 2 research grants (2 CIHR), most recently in 2012.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Cancer Survivorship Chronic Diseases Health Care Organization Participatory Research Planning Primary Care Services

Latest papers

Evaluation and comparison of covariate balance metrics in studies with time-dependent confounding.
Statistics in medicine · 2024
A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases.
Research in social & administrative pharmacy : RSAP · 2024
Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.
Journal of clinical epidemiology · 2024

All 13 publications

Latest funding

Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly - A Causal Perspective to Treatment Trajectory Analysis
CIHR · 2019 · Co-investigator
$279,225
Developing Longitudinal Indicators for Population-Scale Monitoring of Health Care Trajectories
CIHR · 2016 · Co-investigator
$180,000
Une plateforme d'échange sur l'implication des patients dans les activités d'évaluation des technologies et modes d'intervention en santé
CIHR · 2015 · Co-investigator
$10,000

All 8 grants and awards

13 publications.

Evaluation and comparison of covariate balance metrics in studies with time-dependent confounding.

Adenyo D, Guertin JR, Candas B, Sirois C, Talbot D

Statistics in medicine2024

DOI: 10.1002/sim.10188 PMID: 39080838

A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases.

Gagnon ME, Mésidor M, Simard M, Chiu YM, Gosselin M, Candas B, Sirois C

Research in social & administrative pharmacy : RSAP2024

DOI: 10.1016/j.sapharm.2024.05.006 PMID: 38797631

Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.

Mésidor M, Sirois C, Guertin JR, Schnitzer ME, Candas B, Blais C, Cossette B, Poirier P, Brophy JM, Lix L, Tadrous M, Diop A, Hamel D, Talbot D

Journal of clinical epidemiology2024

DOI: 10.1016/j.jclinepi.2024.111284 PMID: 38367659

Marginal structural models with latent class growth analysis of treatment trajectories: Statins for primary prevention among older adults.

Diop A, Sirois C, Guertin JR, Schnitzer ME, Candas B, Cossette B, Poirier P, Brophy J, Mésidor M, Blais C, Hamel D, Tadrous M, Lix L, Talbot D

Statistical methods in medical research2023

DOI: 10.1177/09622802231202384 PMID: 37750253

Response to Precision on the Scope on the Combined Comorbidity Index Published in: Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.

Simard M, Sirois C, Candas B

Medical care2018Senior author

DOI: 10.1097/mlr.0000000000000955 PMID: 30059362

Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.

Simard M, Sirois C, Candas B

Medical care2018Senior author

DOI: 10.1097/mlr.0000000000000905 PMID: 29578951

Barriers and facilitators to implementing continuous quality improvement programs in colonoscopy services: a mixed methods systematic review.

Candas B, Jobin G, Dubé C, Tousignant M, Abdeljelil AB, Grenier S, Gagnon MP

Endoscopy international open2016First author

DOI: 10.1055/s-0041-107901 PMID: 26878037

Involving patient in the early stages of health technology assessment (HTA): a study protocol.

Gagnon MP, Candas B, Desmartis M, Gagnon J, La Roche D, Rhainds M, Coulombe M, Dipankui MT, Légaré F

BMC health services research2014

DOI: 10.1186/1472-6963-14-273 PMID: 24950739

User's perspectives of barriers and facilitators to implementing quality colonoscopy services in Canada: a study protocol.

Jobin G, Gagnon MP, Candas B, Dubé C, Ben Abdeljelil A, Grenier S

Implementation science : IS2010

DOI: 10.1186/1748-5908-5-85 PMID: 21044332

Metabolism of DHEA in postmenopausal women following percutaneous administration.

Labrie F, Bélanger A, Bélanger P, Bérubé R, Martel C, Cusan L, Gomez J, Candas B, Chaussade V, Castiel I, Deloche C, Leclaire J

The Journal of steroid biochemistry and molecular biology2007

DOI: 10.1016/j.jsbmb.2006.09.034 PMID: 17084625

Something wrong or missing on this profile? Suggest a correction

Bernard Candas

Research

Latest papers

Latest funding

Evaluation and comparison of covariate balance metrics in studies with time-dependent confounding.

A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases.

Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.

Marginal structural models with latent class growth analysis of treatment trajectories: Statins for primary prevention among older adults.

Response to Precision on the Scope on the Combined Comorbidity Index Published in: Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.

Validation of the Combined Comorbidity Index of Charlson and Elixhauser to Predict 30-Day Mortality Across ICD-9 and ICD-10.

Barriers and facilitators to implementing continuous quality improvement programs in colonoscopy services: a mixed methods systematic review.

Involving patient in the early stages of health technology assessment (HTA): a study protocol.

User's perspectives of barriers and facilitators to implementing quality colonoscopy services in Canada: a study protocol.

Metabolism of DHEA in postmenopausal women following percutaneous administration.

Real-World Evaluation of the Efficacy, Safety and Cost-Effectiveness of Statins for Primary Prevention of Cardiovascular Disease Among the Elderly - A Causal Perspective to Treatment Trajectory Analysis

Developing Longitudinal Indicators for Population-Scale Monitoring of Health Care Trajectories

Une plateforme d'échange sur l'implication des patients dans les activités d'évaluation des technologies et modes d'intervention en santé

Determinants and optimisation of the primary care practices for the prevention and management of chronic diseases in cancer survivors

Impliquer les patient dans l'identification, la priorisation et l'élaboration du plan d'évaluation des sujets en ETMIS

Dissémination des facteurs clés d'implantation d'un service de qualité en coloscopie

Groupe d'étude sur la transformation des services en coloscopie

Barriers and facilitators to implementation of quality colonoscopy services in Canada: A synthesis of users' perspectives

Frequent collaborators

Caroline Sirois

Denis Talbot

Lisa Lix

Mina Tadrous

Benoît Cossette

Paul Poirier

Marie-Pierre Gagnon

Marc Rhainds

Jacques Simard

James Brophy

Daniel La Roche